West Nile virus fatality confirmed in Hidalgo County

Breaking News
1022

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

EDINBURG – Authorities have confirmed an 83-year-old Donna man died Wednesday night of the West Nile virus; and a 92-year-old from Pharr, Texas man has been hospitalized with what is expected to be the second local case of West Nile.

The Hidalgo County death is the third West Nile virus fatality in Texas this year.

The West Nile virus is a mosquito-borne illness. Persons over 50 years of age and those with weakened immune systems are the most vulnerable, however all residents are urged to take precautions when working or playing outdoors.

- Advertisement -

A statewide campaign, called Fight the Bite, encourages residents to protect themselves from the West Nile virus by following these four steps:

  • Stay indoors at Dusk and Dawn. This is the time of day that mosquitoes are most active.
• Dress in long sleeves/pants, loose and light-colored clothing when outdoors.
• Defend yourself from mosquitoes by using and insect repellent that contains DEET, picaridin or oil of lemon eucalyptus.
• Drain standing water in your yard and neighborhood. Also make sure that flower pots, water dishes, bird baths and wading pools are properly drained so they are not breeding grounds for mosquitoes.
- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Health providers have an opportunity to further their education
Next article
Brush Country Medicine And Survival Conference Set For October 18, 2014

More Articles

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.
- Advertisement -